Literature DB >> 24559522

Tantalum acetabular augments in one-stage exchange of infected total hip arthroplasty: a case-control study.

Till Orla Klatte1, Daniel Kendoff2, Reza Sabihi2, Atul F Kamath3, Johannes M Rueger1, Thorsten Gehrke2.   

Abstract

During the one-stage exchange procedure for periprosthetic joint infection (PJI) after total hip arthroplasty (THA), acetabular defects challenge reconstructive options. Porous tantalum augments are an established tool for addressing acetabular destruction in aseptic cases, but their utility in septic exchange is unknown. This retrospective case-control study presents the initial results of tantalum augmentation during one-stage exchange for PJI. Primary endpoints were rates of re-infection and short-term complications associated with this technique. Study patients had no higher risk of re-infection with equivalent durability at early follow-up with a re-infection rate in both groups of 4%. In conclusion, tantalum augments are a viable option for addressing acetabular defects in one-stage exchange for septic THA. Further study is necessary to assess long-term durability when compared to traditional techniques for acetabular reconstruction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acetabular defects; one-stage exchange; periprosthetic infection; tantalum augments; total hip arthroplasty

Mesh:

Substances:

Year:  2014        PMID: 24559522     DOI: 10.1016/j.arth.2014.01.011

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

1.  Tritanium acetabular wedge augments: short-term results.

Authors:  Camilo Restrepo; Snir Heller; Antonia F Chen
Journal:  Ann Transl Med       Date:  2016-06

2.  [Short-term effectiveness of acetabular reconstruction with three-dimensional printed trabecular metal pads in hip revision].

Authors:  Zhongyuan Zhang; Jinwei Zhao; Xiangjie Huang; Hexun Jiang; Ziyao Xu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.